1. Home
  2. INMD vs VOR Comparison

INMD vs VOR Comparison

Compare INMD & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$14.81

Market Cap

842.0M

Sector

Health Care

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$20.65

Market Cap

813.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INMD
VOR
Founded
2008
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
842.0M
813.3M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
INMD
VOR
Price
$14.81
$20.65
Analyst Decision
Hold
Buy
Analyst Count
5
10
Target Price
$17.33
$45.33
AVG Volume (30 Days)
739.4K
1.5M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.74
N/A
Revenue Next Year
$3.26
N/A
P/E Ratio
$10.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.72
$1.62
52 Week High
$16.74
$49.95

Technical Indicators

Market Signals
Indicator
INMD
VOR
Relative Strength Index (RSI) 66.80 76.17
Support Level $14.58 $11.62
Resistance Level $15.23 $49.95
Average True Range (ATR) 0.27 1.32
MACD 0.14 0.65
Stochastic Oscillator 80.30 81.41

Price Performance

Historical Comparison
INMD
VOR

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: